Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1998 1
2009 1
2010 1
2011 1
2013 3
2014 2
2015 2
2016 4
2018 2
2019 3
2020 5
2021 10
2022 18
2023 5
2024 4
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
The Rare Gynecologic Sarcoma Study: Molecular and Clinicopathologic Results of A Project on 379 Uterine Sarcomas.
Dundr P, Hojný J, Dvořák J, Hájková N, Vránková R, Krkavcová E, Berjon A, Bizoń M, Bobiński M, Bouda J, Bui QH, Căpîlna ME, Ciccarone F, Flídrová M, Fröbe A, Grabowska K, Halaška MJ, Hausnerová J, Jedryka M, Laco J, Kalist V, Klát J, Kolníková G, Książek M, Marek R, Matěj R, Michal M, Michalová K, Ndukwe M, Němejcová K, Petróczy D, Piatnytska T, Póka R, Poprawski T, Ryś J, Sawicki W, Sharashenidze A, Stolnicu S, Stružinská I, Špůrková Z, Volodko N, Zapardiel I, Zikán M, Židlík V, Cibula D, Poncová R, Kendall Bártů M. Dundr P, et al. Among authors: frobe a. Lab Invest. 2025 May;105(5):104092. doi: 10.1016/j.labinv.2025.104092. Epub 2025 Feb 5. Lab Invest. 2025. PMID: 39921027
Genetics of Prostate Carcinoma.
Krušlin B, Škara L, Vodopić T, Vrhovec B, Murgić J, Štimac G, Fröbe A, Lež C, Ulamec M, Gall-Trošelj K. Krušlin B, et al. Among authors: frobe a. Acta Med Acad. 2021 Apr;50(1):71-87. doi: 10.5644/ama2006-124.327. Acta Med Acad. 2021. PMID: 34075765 Free article. Review.
MRI-GUIDED RADIOTHERAPY FOR PROSTATE CANCER: A NEW PARADIGM.
Murgić J, Gregov M, Mrčela I, Budanec M, Krengli M, Fröbe A, Franco P. Murgić J, et al. Among authors: frobe a. Acta Clin Croat. 2022 Oct;61(Suppl 3):65-70. doi: 10.20471/acc.2022.61.s3.9. Acta Clin Croat. 2022. PMID: 36938552 Free PMC article. Review.
A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors.
Khaki AR, Li A, Diamantopoulos LN, Miller NJ, Carril-Ajuria L, Castellano D, De Kouchkovsky I, Koshkin V, Park J, Alva A, Bilen MA, Stewart T, Santos V, Agarwal N, Jain J, Zakharia Y, Morales-Barrera R, Devitt M, Nelson A, Hoimes CJ, Shreck E, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Rodriguez-Vida A, Drakaki A, Liu S, Kumar V, Lythgoe MP, Pinato DJ, Murgic J, Fröbe A, Joshi M, Isaacsson Velho P, Hahn N, Alonso Buznego L, Duran I, Moses M, Barata P, Galsky MD, Sonpavde G, Yu EY, Shankaran V, Lyman GH, Grivas P. Khaki AR, et al. Among authors: frobe a. Eur Urol Oncol. 2021 Jun;4(3):464-472. doi: 10.1016/j.euo.2020.12.006. Epub 2021 Jan 7. Eur Urol Oncol. 2021. PMID: 33423945 Free PMC article.
Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer: The VIABLE Phase 3 Randomized Clinical Trial.
Vogelzang NJ, Beer TM, Gerritsen W, Oudard S, Wiechno P, Kukielka-Budny B, Samal V, Hajek J, Feyerabend S, Khoo V, Stenzl A, Csöszi T, Filipovic Z, Goncalves F, Prokhorov A, Cheung E, Hussain A, Sousa N, Bahl A, Hussain S, Fricke H, Kadlecova P, Scheiner T, Korolkiewicz RP, Bartunkova J, Spisek R; VIABLE Investigators. Vogelzang NJ, et al. JAMA Oncol. 2022 Apr 1;8(4):546-552. doi: 10.1001/jamaoncol.2021.7298. JAMA Oncol. 2022. PMID: 35142815 Free PMC article. Clinical Trial.
SAFETY CONSIDERATIONS IN RADIOTHERAPY.
Budanec M, Mrčela I, Gregov M, Mlinarić M, Matanić A, Fröbe A. Budanec M, et al. Among authors: frobe a. Acta Clin Croat. 2019 Nov;58(Suppl 2):82-83. doi: 10.20471/acc.2019.58.s2.14. Acta Clin Croat. 2019. PMID: 34975204 Free PMC article. Review. No abstract available.
Response and Survival With Immune Checkpoint Inhibitor in Patients With Advanced Urothelial Carcinoma and Histology Subtypes.
Bakaloudi DR, Talukder R, Enright T, Leary JB, Makrakis D, Diamantopoulos LN, Hobeika C, Thomas VM, Swami U, Zakopoulou R, Bamias A, Brown JR, Pinato DJ, Latchford C, Jindal T, Koshkin VS, Murgić J, Miletić M, Frobe A, Johnson J, Zakharia Y, Alva A, Nguyen CB, Hui G, Drakaki A, Rodriguez-Vida A, Rey-Cárdenas M, Castellano D, Buznego LA, Duran I, Barrera RM, Marmolejo D, McKay RR, Stewart TF, Barata P, Epstein IB, Bellmunt J, Yu EY, Raychaudhuri R, Nadal R, Vakar-Lopez F, Gupta S, Wright JL, Khaki AR, Grivas P. Bakaloudi DR, et al. Among authors: frobe a. Clin Genitourin Cancer. 2025 Aug;23(4):102356. doi: 10.1016/j.clgc.2025.102356. Epub 2025 Apr 14. Clin Genitourin Cancer. 2025. PMID: 40378559
The extracellular matrix component perlecan/HSPG2 regulates radioresistance in prostate cancer cells.
Samaržija I, Lukiyanchuk V, Lončarić M, Rac-Justament A, Stojanović N, Gorodetska I, Kahya U, Humphries JD, Fatima M, Humphries MJ, Fröbe A, Dubrovska A, Ambriović-Ristov A. Samaržija I, et al. Among authors: frobe a. Front Cell Dev Biol. 2024 Aug 1;12:1452463. doi: 10.3389/fcell.2024.1452463. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39149513 Free PMC article.
62 results